FEDERALlobbying filing

Lobbying Disclosure: ACG Advocacy for Artera (Q2 2026)

Original title: ACG Advocacy → Artera (2nd Quarter Report 2026)

July 20, 2026

Lobbying Health Care Telecommunications Artificial Intelligence Government Procurement

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

This filing discloses that Artera paid $50,000 to ACG Advocacy to influence federal policy on health care procurement and artificial intelligence regulations.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Artera

The company is the client paying for lobbying services to influence federal policy.

ACG Advocacy

The firm is the registrant responsible for filing the disclosure and performing the lobbying activities.

What changed

Last recorded activity July 20, 2026.

What's next

Next step not available in the current record.

Summary

This document is a quarterly lobbying report filed by ACG Advocacy regarding their work for the client Artera. It outlines the specific policy areas the firm lobbied on and the federal agencies they contacted during the second quarter of 2026.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

This filing discloses that Artera paid $50,000 to ACG Advocacy to influence federal policy on health care procurement and artificial intelligence regulations.

Frequently Asked Questions

What is this document?

This is a mandatory quarterly lobbying disclosure report showing which companies are paying firms to influence federal policy and which agencies those firms are contacting.

How much was spent on this lobbying effort?

The report states that ACG Advocacy received $50,000 from Artera for lobbying services during this quarter.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Lobbying Activity

ACG Advocacy

on behalf of Artera

2026

HEALTH ISSUESTELECOMMUNICATIONS

“Government procurement health care.”

View filing →

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

financial connection100% confidence

Lobbying Expenditure

Artera utilized ACG Advocacy to target four distinct federal agencies regarding AI policy and health care procurement.

Artera ACG Advocacy

Connected Entities

personChris Minakowski“Lobbyist for ACG Advocacy.”Map →

organizationArtera“The client paying for lobbying services.”Map →

organizationExecutive Office of the President“Targeted federal agency.”Map →

organizationACG Advocacy“The registrant firm filing the report.”Map →

organizationVeterans Affairs“Targeted federal agency.”Map →

organizationU.S. Senate“Targeted federal agency.”Map →

personSarah Kohn“Lobbyist for ACG Advocacy.”Map →

personChris Israel“Lobbyist for ACG Advocacy.”Map →

organizationU.S. House of Representatives“Targeted federal agency.”Map →

Sources

Open source document

disclosurespreview.house.gov

Analysis Score

0–100

Significance40
How much this matters to a regular citizen
Controversy20
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz10
Current news / social attention level

Publisher tools